Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 21Central Nervous System Neoplasms 6Glioma 5Neoplasm Metastasis 4Glioblastoma 4Radiation Injuries 3Small Cell Lung Carcinoma 2Oligodendroglioma 2Neurotoxicity Syndromes 2Neoplasms 2Meningioma 2Medulloblastoma 2Lung Neoplasms 2Gliosarcoma 2Ependymoma 2Craniopharyngioma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Seizures 1Pinealoma 1Ototoxicity 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Meningeal Carcinomatosis 1Melanoma 1Glioma, Subependymal 1Fatigue 1Cognitive Dysfunction 1Cognition Disorders 1

Interventions

Specimen Handling 1Mental Status and Dementia Tests 1Memantine 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Carcinoma × Mental Status and Dementia Tests × CNS × Clear all
NCT04939597 2025-12-22

A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor

Children's Oncology Group

Phase 3 Active not recruiting
192 enrolled
CNS

Central Nervous System Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡